Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anavex Life Sciences

8.23
-0.6800-7.63%
Post-market: 8.760.5300+6.44%19:50 EDT
Volume:1.12M
Turnover:9.41M
Market Cap:700.08M
PE:-14.90
High:8.79
Open:8.69
Low:8.20
Close:8.91
Loading ...
Jun 24, 2021

Major Issues Report

8-K - Current report
May 28, 2021

Major Issues Report

8-K - Current report
May 13, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 09, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 16, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 02, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 28, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Dec 28, 2020

Major Issues Report

8-K - Current report
Dec 15, 2020

Major Issues Report

8-K - Current report
Nov 06, 2020

Major Issues Report

8-K - Current report
Oct 15, 2020

Major Issues Report

8-K - Current report
Aug 06, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 02, 2020

Major Issues Report

8-K - Current report
May 07, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 01, 2020

Major Issues Report

Current report, items 1.01, 8.01, and 9.01
Apr 08, 2020

Major Issues Report

Current report, item 5.07
Mar 09, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals